- Conditions
- Trigeminal Neuralgia
- Interventions
- Basimglurant, Placebo
- Drug · Other
- Lead sponsor
- Noema Pharma AG
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 166 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 8
- States / cities
- La Jolla, California • Miami, Florida • Tampa, Florida + 5 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–6
of 6
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Trigeminal Neuralgia
- Interventions
- Pain Diary use
- Other
- Lead sponsor
- Noema Pharma AG
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 30 participants
- Timeline
- 2021 – 2023
- U.S. locations
- 1
- States / cities
- La Jolla, California
- Conditions
- Childhood-Onset Fluency Disorder
- Interventions
- NOE-105, Placebo
- Drug
- Lead sponsor
- Noema Pharma AG
- Industry
- Eligibility
- 18 Years to 55 Years · Male only
- Enrollment
- 75 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 6
- States / cities
- Bellflower, California • Jacksonville, Florida • Orlando, Florida + 3 more
- Conditions
- Tourette Syndrome
- Interventions
- Gemlapodect, Placebo
- Drug
- Lead sponsor
- Noema Pharma AG
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 164 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 31
- States / cities
- Sun City, Arizona • Bellflower, California • Glendale, California + 28 more
- Conditions
- Menopause Syndrome, Menopause, Hot Flashes
- Interventions
- NOE-115
- Drug
- Lead sponsor
- Noema Pharma AG
- Industry
- Eligibility
- 45 Years to 60 Years · Female only
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 5
- States / cities
- San Diego, California • Jacksonville, Florida • Atlanta, Georgia + 2 more
- Conditions
- Tuberous Sclerosis Complex
- Interventions
- Basimglurant with crossover to Placebo, Placebo with crossover to Basimglurant
- Drug
- Lead sponsor
- Noema Pharma AG
- Industry
- Eligibility
- 5 Years to 30 Years
- Enrollment
- 61 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 9
- States / cities
- Los Angeles, California • Baltimore, Maryland • Boston, Massachusetts + 6 more